Expert Review of Anti-Infective Therapy

5.3(top 5%)

impact factor

2.0K(top 10%)

papers

60.8K(top 5%)

citations

97(top 5%)

h-index

5.9(top 5%)

impact factor

2.7K

all documents

65.4K

doc citations

149(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Clinical relevance of the ESKAPE pathogens	Expert Review of Anti-Infective Therapy	2013	1,064
2	Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects	Expert Review of Anti-Infective Therapy	2011	714
3	Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes	Expert Review of Anti-Infective Therapy	2012	520
4	Mechanisms of antibiotic resistance in enterococci	Expert Review of Anti-Infective Therapy	2014	507
5	Alternative mechanisms of action of cationic antimicrobial peptides on bacteria	Expert Review of Anti-Infective Therapy	2007	450
6	Colistin: an update on the antibiotic of the 21st century	Expert Review of Anti-Infective Therapy	2012	434
7	Chronic wound infections: the role ofPseudomonas aeruginosaandStaphylococcus aureus	Expert Review of Anti-Infective Therapy	2015	434
8	The silent threat: asymptomatic parasitemia and malaria transmission	Expert Review of Anti-Infective Therapy	2013	405
9	Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis	Expert Review of Anti-Infective Therapy	2010	363
10	Infectious diseases following natural disasters: prevention and control measures	Expert Review of Anti-Infective Therapy	2012	348
11	Role of the gut microbiota in defining human health	Expert Review of Anti-Infective Therapy	2010	339
12	Resistance in bacteria of the food chain: epidemiology and control strategies	Expert Review of Anti-Infective Therapy	2008	302
13	Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents	Expert Review of Anti-Infective Therapy	2011	300
14	Biofilm-related disease	Expert Review of Anti-Infective Therapy	2018	299
15	Candida albicansdimorphism as a therapeutic target	Expert Review of Anti-Infective Therapy	2012	292
16	Discovery, mechanisms of action and combination therapy of artemisinin	Expert Review of Anti-Infective Therapy	2009	283
17	Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities	Expert Review of Anti-Infective Therapy	2009	282
18	Clinical and economic burden of antimicrobial resistance	Expert Review of Anti-Infective Therapy	2008	259
19	Multidrug-resistantPseudomonas aeruginosaandAcinetobacter baumannii: resistance mechanisms and implications for therapy	Expert Review of Anti-Infective Therapy	2010	256
20	Meeting the public health challenge of multidrug- and extensively drug-resistantNeisseria gonorrhoeae	Expert Review of Anti-Infective Therapy	2009	250
21	Emergence and management of drug-resistant enterococcal infections	Expert Review of Anti-Infective Therapy	2008	239
22	Bacterial biofilms: a diagnostic and therapeutic challenge	Expert Review of Anti-Infective Therapy	2003	231
23	Epidemiology and control of human gastrointestinal parasites in children	Expert Review of Anti-Infective Therapy	2010	216
24	Potential of old-generation antibiotics to address current need for new antibiotics	Expert Review of Anti-Infective Therapy	2008	201
25	A clear and present danger: tick-borne diseases in Europe	Expert Review of Anti-Infective Therapy	2010	201
26	Prevention and treatment ofStaphylococcus aureusbiofilms	Expert Review of Anti-Infective Therapy	2015	201
27	Propionibacterium acnes: infection beyond the skin	Expert Review of Anti-Infective Therapy	2011	197
28	Serologic assays for influenza surveillance, diagnosis and vaccine evaluation	Expert Review of Anti-Infective Therapy	2011	196
29	An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies	Expert Review of Anti-Infective Therapy	2021	184
30	Azole antifungals: 35 years of invasive fungal infection management	Expert Review of Anti-Infective Therapy	2015	179
31	Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections?	Expert Review of Anti-Infective Therapy	2012	177
32	Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin	Expert Review of Anti-Infective Therapy	2012	171
33	Evidence for a causal relationship between respiratory syncytial virus infection and asthma	Expert Review of Anti-Infective Therapy	2011	167
34	Antimicrobial peptides: therapeutic potentials	Expert Review of Anti-Infective Therapy	2014	167
35	Azithromycin in the treatment of COVID-19: a review	Expert Review of Anti-Infective Therapy	2021	167
36	Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature	Expert Review of Anti-Infective Therapy	2015	165
37	Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance	Expert Review of Anti-Infective Therapy	2006	163
38	Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens	Expert Review of Anti-Infective Therapy	2011	163
39	COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up	Expert Review of Anti-Infective Therapy	2021	157
40	Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide	Expert Review of Anti-Infective Therapy	2015	156
41	Community-acquiredAcinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis	Expert Review of Anti-Infective Therapy	2015	150
42	Biomarkers for pediatric sepsis and septic shock	Expert Review of Anti-Infective Therapy	2011	146
43	Between a bug and a hard place:Trypanosoma cruzigenetic diversity and the clinical outcomes of Chagas disease	Expert Review of Anti-Infective Therapy	2015	146
44	Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease	Expert Review of Anti-Infective Therapy	2014	145
45	The utility of diagnostic tests for enteric fever in endemic locations	Expert Review of Anti-Infective Therapy	2011	143
46	Point of care diagnostics for sexually transmitted infections: perspectives and advances	Expert Review of Anti-Infective Therapy	2014	143
47	Potential antivirals and antiviral strategies against SARS coronavirus infections	Expert Review of Anti-Infective Therapy	2006	142
48	Polymyxin B: similarities to and differences from colistin (polymyxin E)	Expert Review of Anti-Infective Therapy	2007	142
49	PCR-based diagnosis of human fungal infections	Expert Review of Anti-Infective Therapy	2009	140
50	Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection	Expert Review of Anti-Infective Therapy	2013	140

Scientometrics

Overviews

Citing Bodies

Expert Review of Anti-Infective Therapy

Top Articles